VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease.
$0.14+1.24%
报价 2026-11-09
市值
$2.4M
EV
$-3.6M
PE (TTM)
–
预期 PE (FY2027)
–
52 周区间距高点 -95.1%
$0.14$2.92
筛选结果
pipeline · 2026-11-09Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| VIVSVivoSim Labs, Inc. | $2.4M | +1.2% | 0.0% | -100.8% | – | – | – | |
| IBOImpact BioMedical Inc. | $34.6M | -2.2% | – | -1,111.4% | – | – | – | |
| KTTAPasithea Therapeutics Corp. | $18.1M | -6.3% | -100.0% | 0% | – | – | – | |
| PLRZPolyrizon Ltd. | $12.4M | +0.0% | – | 0% | – | – | – | |
| QNRXQuoin Pharmaceuticals, Ltd. | $7.8M | +7.0% | – | 0% | – | – | – | |
| TCRTAlaunos Therapeutics, Inc. | $5.7M | -4.0% | -84.3% | -28,133.3% | – | – | – | |
| PMCBPharmaCyte Biotech, Inc. | $4.4M | +13.1% | – | 0% | – | – | – | |
| XTLBXTL Biopharmaceuticals Ltd. | $1.4M | -1.3% | – | 0% | – | – | – | |
| RADXRadiopharm Theranostics Limited | $1.1M | -7.7% | – | -39.4% | – | – | – | |
| 同行中位数 | – | – | -92.1% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。